Use of Virtual Reality to Communicate Concepts of Genomics to the General Public
NCT ID: NCT00316056
Last Updated: 2017-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
346 participants
OBSERVATIONAL
2006-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
English-speaking men and women between 18 and 40 years of age may be eligible for this study. Participants are randomly assigned to one of two groups, each of which receives a different type of information, once in the IVE lab. Subjects complete a questionnaire before and after performing the activities in the lab. The questionnaire evaluates the subject's knowledge of genetics and tests some reading and number skills.
...
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VIGOR: Virtual Genome Center for Infant Health
NCT05205356
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
NCT03829176
Genetic Inclusion by Virtual Evaluation
NCT05318222
Physicians' Understanding of Human Genetic Variation
NCT00339924
Surveying Parents About Genome Screening of Newborns
NCT01736501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
Because we are interested in how members of the general public learn best about genomic topics, participants in this study will be healthy adults. Individuals who are particularly susceptible to motion sickness will be excluded. Therefore, all participants will be screened for the following conditions prior to enrollment in the study: self-reported diagnosis with epilepsy, low vision, hearing problems, or vestibular disorders (e.g., dizziness, vertigo, motion sickness).
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Human Genome Research Institute (NHGRI)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bailenson JN, Blascovich J, Beall AC, Loomis JM. Interpersonal distance in immersive virtual environments. Pers Soc Psychol Bull. 2003 Jul;29(7):819-33. doi: 10.1177/0146167203029007002.
Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns. 1999 Sep;38(1):33-42. doi: 10.1016/s0738-3991(98)00116-5.
Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA. 2001 Feb 7;285(5):540-4. doi: 10.1001/jama.285.5.540.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-HG-0143
Identifier Type: -
Identifier Source: secondary_id
060143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.